Sapheon hauls in $10M as it works toward FDA approval for a varicose vein device

North Carolina's Sapheon pulled down $10 million in financing to support the development of its VenaSeal system, a varicose vein-treating device going through the FDA's modular approval program. Under the agency's guidance, Sapheon has submitted the second round of data on VenaSeal and is in the midst of a 242-patient pivotal trial with hopes of getting the device approved by 2015. More